Nano-Enabled Drugs: Once Bitten, Twice Shy?
Nanotech-based reformulations of existing drugs have failed to inspire Big
Pharma – but truly nano-enabled drugs offer real potential for innovation
and companies ignore them at their peril.
By Jon Howells and Carys Lloyd at PA Consulting Group (December 2009)
Keywords: Nano-Enabled Drugs, reformulations, Big Pharma, PA COnsulting Group, Howells, Lloyd, Targeted Drug Discovery, Synergistic Collaborations, Metrology